Partner
Peter Van Vlasselaer
Venture Partner, NanoDimension
- Firm
- NanoDimension
- Title
- Venture Partner
- Role
- Venture partner
- Known as
- Investor
Claim, correct or request removal
Record updated 20 September 2026
About
Peter joined +ND Capital in 2019. He was most recently the Founder, President and Chief Executive Officer of ARMO Biosciences, Inc. which was acquired by Eli Lilly in June 2018 shortly after its public offering (Nasdaq: ARMO).
Is this you? Remove my profile
Loading relationship preview